IDH (isocitrate dehydrogenase) converts isocitrate to α-KG (α-ketoglutarate), a tumor-suppressing metabolite of P53, which compensates for P53 deficiency to arrest malignant progression [57]. The gene discussed is TP53; the disease is neoplasm.